In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been demonstrated to be highly effective against both P. falciparum and P. vivax and well-tolerated in Africa and Asia [21–25].”
In the citing paper
“However, the findings are consistent with previous reports of high efficacy for both P. falciparum and P. vivax from elsewhere and the extended protection to day 42 attributed to piperaquine's longer half-life [21–25].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424 · cited 3×
“falciparum should be maintained and containment activities should be further strengthened to monitor the spread of resistance, define therapeutic and operational strategies to understand its molecular basis and counter its impact [28,42].”
BackgroundQinghaosu (Artemisinin): The Price of Success
White, N. J. (2008) · Science · doi:10.1126/science.1155165 · Cited by 954 · cited 2×
“The reduced susceptibility of ring-stage parasites causes the slow parasite clearance [29-33].”
BackgroundThe changing epidemiology of malaria elimination: New strategies for new challenges
Cotter, C., Sturrock, H. J., Hsiang, M. S., Liu, J., Phillips, A. A., Hwang, J., Gueye, C. S., Fullman, N., Gosling, R. D., & Feachem, R. G. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60310-4 · Cited by 671 · cited 1×
“In eliminating settings, malaria predominantly occurs in border areas and imported cases tend to represent a majority of recorded cases [19].”
BackgroundCarrara, V. I., Lwin, K. M., Phyo, A. P., Ashley, E., Wiladphaingern, J., Sriprawat, K., Rijken, M., Boel, M., McGready, R., Proux, S., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001398 · Cited by 185 · cited 1×
“falciparum, the strategy of EDT with ACT has reduced malaria in the migrant population living on the Thai-Myanmar border [48].”
Background
Research works printed but not linked: 44
- WHO. World malaria report 2012. Geneva: World Health Organization; 2012.
- WHO. The global plan for artemisinin resistance containment. Geneva: World Health Organization; 2011.
- Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, et al. Novel phenotypic assays detect artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug response studies. Lancet Infect Dis. 2013;13:1043–9. · DOI · Paper page
- Noedl H, Se Y, Schaecher K, Smith B, Socheat D, Fukuda M. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619–20. · DOI · Paper page
- Amaratunga C, Sreng S, Suon S, Phelps E, Stepniewska K, Lim P, et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis. 2012;12:851–8. · DOI · Paper page
- Amaratunga C, Mao S, Sreng S. Slow parasite clearance rates in response to artemether in patients with severe malaria. Lancet Infect Dis. 2013;13:113–4. · DOI
- Hien TT, Thuy-Nhien NT, Phu NH. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam. Malar J. 2012;11:355. · DOI · Paper page
- Phyo AP, Nkhoma S, Stepniewska K, Ashley E, Nair S, Gready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960–6. · DOI · Paper page
- Bangchang K, Karbwang J. Emerging artemisinin resistance in the border areas of Thailand. Clin Pharmacol. 2013;6:307–22.
- Kyaw MP, Nyunt MH, Chit K. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS One. 2013;8:e57689. · DOI · Paper page
- WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2006. p. 1–66.
- MOH of People’s Republic of China. From malaria control to elimination: a revised national malaria strategy 2010–2015. Beijing: Ministry of Health; 2009. p. 2–4.
- MOH of People’s Republic of China. Malaria elimination action plan 2010–2020. Beijing: Ministry of Health; 2010. p. 1–2 [in Chinese].
- MOH of People’s Republic of China. Malaria control manual. Beijing: Ministry of Health; 2007. p. 33–43 [in Chinese].
- Martens P, Hall L. Malaria on the move: human population movement and malaria transmission. Emerg Infect Dis. 2000;6:103–9. · DOI · Paper page
- Xu JW, Liu H. The challenges of malaria elimination in yunnan province, people’s republic of China. Southeast Asian J Trop Med Public Health. 2012;43:819–24.
- Petersen I, Eastman R, Lanzer M. Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett. 2011;585:1551–62. · DOI · Paper page
- Bräutigam D. Local entrepreneurship in Southeast Asia and Subsaharan Africa: networks and linkages to the global economy. Washington, DC: School of International Service, American University; 1998.
- WHO. Method for surveillance of antimalarial drug efficacy. Geneva: World Health Organization; 2009. p. 12–82.
- Liu H, Yang HL, Xu JW, Wang JZ, Nie RH, Li CF. Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China. Malar J. 2013;12:409. · DOI · Paper page
- Yang HL, Yang Y, Yang PF. Monitoring Plasmodium falciparum chloroquine resistance in Yunnan Province, China, 1981–2006. Acta Trop. 2008;108:44–9. · doi:10.1016/j.actatropica.2008.08.010
- WHO. Methods and techniques for clinical trials on antimalarial efficacy: genotyping to identify parasite populations. Geneva: World Health Organization; 2008.
- Nhama A, Bassat Q, Enosse S, Nhacolo A, Mutemba R, Carvalho E, et al. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique. Malar J. 2014;13:309. · doi:10.1186/1475-2875-13-309
- Stepniewska K, White NJ. Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria. Malar J. 2006;5:127. · DOI
- Xu JW, Liao YM, Liu H, Nie RH, Havumaki J. Use of bed nets and factors that influence bed net use among Jinuo ethnic minority in Southern China. PLoS One. 2014;9:e103780. doi:10.1371/journal.pone.0103780. · DOI
- Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50–5. · DOI · Paper page
- Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeug N, et al. Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother. 2013;57:914–23. · DOI · Paper page
- Mok S, Imwong M, Mackinnon MJ, Sim J, Ramadoss R, Yi P, et al. Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics. 2011;12:391. · DOI · Paper page
- Chotivanich K, Tripura R, Das D, Yi P, Day N, Pukrittayakamee S. Laboratory detection of artemisinin resistant Plasmodium falciparum. Antimicrob Agents Chemother. 2014;58:3157–61. · DOI
- Sun XD, Zhang ZX, Liu DQ. Clinical study on the efficacy of dihyroartemisinin and piperaquine in treatment of multi-drug resistant Plasmodium falciparum [in Chinese]. Chin Trop Med. 2006;6:211–2.
- Liu H, Yang HL, Zhang J, Li CF, Nie RH, Wang HY. Clinical trial on efficacy of compound dihydroartemisinin-piperaquine for treatment of uncomplicated falciparum malaria in Myanmar [in Chinese]. Chin J Parasit Parasitic Dis. 2011;29:296–8.
- Huang F, Tang LH, Yang HL, Zhou SS, Sun XD, Liu H. Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border. Malar J. 2012;11:278. · DOI
- Wang Z, Parker D, Meng H, Wu L, Li J, Zhao Z, et al. In vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genes. PLoS One. 2012;7:e30927. doi:10.1371/ journal.pone.0030927. · DOI
- WHO. Methods and techniques for assessing exposures to antimalarial drugs in clinical field studies. Geneva: World Health Organization; 2011.
- WHO. Status report on artemisinin resistance. Geneva: World Health Organization; 2014.
- Kyaw TT, Hlaing T, Thimasarn K, Mon KM, Galappaththy G, Plasai V, et al. Containing artemisinin resistance of Plasmodium falciparum in Myanmar: Achievements, challenges and the way forward. Southeast Asia J Public Health. 2014;3:90–4. · doi:10.4103/2224-3151.206893
- Yuan LL, Zhao H, Lanou Wu L, Li XM, Parkerd D, Xu SH, et al. Plasmodium falciparum populations from northeastern Myanmar display high levels of genetic diversity at multiple antigenic loci. Acta Trop. 2013;125:53–9. · DOI
- Briena CO, Henricha P, Passia N, Fidock D. Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Curr Opin Infect Dis. 2011;24:570–7. · DOI
- Krishna S, Kremsner PG. Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy. Trends Parasitol. 2013;29:313–7. · DOI
- Guerin PJ, Bates SJ, Sibley CH. Global resistance surveillance: ensuring antimalarial efficacy in the future. Curr Opin Infect Dis. 2009;22:593–600. · DOI
- Song JP, Chen PQ, Xu Y. Randomized-control trial of compound dihydroartemisinin in treating uncomplicated falciparum malaria in Hainan Province of China [in Chinese]. J Guangzhou Uni of Trad Chin Med. 2004;21:9–12.
- Wang SQ, Christophel EM, Lin SG. Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan [in Chinese]. Chin J Parasit Parasitic Dis. 2008;26:50–2.
- Xia ZG, Yang MN, Zhou SS. Malaria situation in the People’s Republic of China in 2011 [in Chinese]. Chin J Parasitol Parasit Dis. 2012;30:419–22.
- White N. Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis. 2013;13:175–81. · DOI
Cited by
Leang, R., Taylor, W. R. J., Bouth, D. M., Song, L., Tarning, J., Char, M. C., Kim, S., Witkowski, B., Duru, V., Domergue, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00835-15 · Cited by 302
Assefa, A., Mohammed, H., Anand, A., Abera, A., Sime, H., Minta, A. A., Tadesse, M., Tadesse, Y., Girma, S., Bekele, W., et al. (2022) · Malaria Journal · doi:10.1186/s12936-022-04350-z · Cited by 20
Metadata
- Authors
- Liu, H., Yang, H.-L., Tang, L.-H., Li, X.-L., Huang, F., Wang, J.-Z., Li, C.-F., Wang, H.-Y., Nie, R.-H., Guo, X.-R., Lin, Y.-X., Li, M., Wang, J., & Xu, J.-W.
- Venue
- Malaria Journal
- Published
- 2015-02-05
- Volume
- 14
- Issue
- 1
- ISSN
- 1475-2875
- Cited by
- 30
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013. https://app.cochat.ai/papers/10.1186/s12936-015-0584-8
- The paper
- Liu, H., Yang, H.-L., Tang, L.-H., Li, X.-L., Huang, F., Wang, J.-Z., Li, C.-F., Wang, H.-Y., Nie, R.-H., Guo, X.-R., Lin, Y.-X., Li, M., Wang, J., & Xu, J.-W. (2015). In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013. Malaria Journal. https://doi.org/10.1186/s12936-015-0584-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.